^Asuka Kaizaki-Mitsumoto; Naoki Noguchi; Saki Yamaguchi; Yuki Odanaka; Satoko Matsubayashi; Hiroki Kumamoto; Kiyoshi Fukuhara; Masahiko Funada; Kiyoshi Wada; Satoshi Numazawa (November 2015). "Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market". Forensic Toxicology. 34: 108–114. doi:10.1007/s11419-015-0293-6.